These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 19406036

  • 1. Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: necessity of immunosuppressive treatment for sustained improvement.
    Toriumi H, Yoshikawa M, Matsuda R, Nishimura F, Yamada S, Hirabayashi H, Nakase H, Nonaka J, Ouji Y, Ishizaka S, Sakaki T.
    Neurol Res; 2009 Apr; 31(3):220-7. PubMed ID: 19406036
    [Abstract] [Full Text] [Related]

  • 2. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells.
    Nishimura F, Yoshikawa M, Kanda S, Nonaka M, Yokota H, Shiroi A, Nakase H, Hirabayashi H, Ouji Y, Birumachi J, Ishizaka S, Sakaki T.
    Stem Cells; 2003 Apr; 21(2):171-80. PubMed ID: 12634413
    [Abstract] [Full Text] [Related]

  • 3. Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's.
    Meissner KK, Kirkham DL, Doering LC.
    Brain Res; 2005 Sep 28; 1057(1-2):105-12. PubMed ID: 16140285
    [Abstract] [Full Text] [Related]

  • 4. Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration.
    Baier PC, Schindehütte J, Thinyane K, Flügge G, Fuchs E, Mansouri A, Paulus W, Gruss P, Trenkwalder C.
    Stem Cells; 2004 Sep 28; 22(3):396-404. PubMed ID: 15153616
    [Abstract] [Full Text] [Related]

  • 5. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539
    [Abstract] [Full Text] [Related]

  • 6. Optimal conditions for in vivo induction of dopaminergic neurons from embryonic stem cells through stromal cell-derived inducing activity.
    Morizane A, Takahashi J, Takagi Y, Sasai Y, Hashimoto N.
    J Neurosci Res; 2002 Sep 15; 69(6):934-9. PubMed ID: 12205686
    [Abstract] [Full Text] [Related]

  • 7. Transplantation of mouse CGR8 embryonic stem cells producing GDNF and TH protects against 6-hydroxydopamine neurotoxicity in the rat.
    Liu TW, Ma ZG, Zhou Y, Xie JX.
    Int J Biochem Cell Biol; 2013 Jul 15; 45(7):1265-73. PubMed ID: 23535049
    [Abstract] [Full Text] [Related]

  • 8. Transplantation of fetal ventral mesencephalic progenitor cells overexpressing high molecular weight fibroblast growth factor 2 isoforms in 6-hydroxydopamine lesioned rats.
    Rumpel R, Hohmann M, Klein A, Wesemann M, Baumgärtner W, Ratzka A, Grothe C.
    Neuroscience; 2015 Feb 12; 286():293-307. PubMed ID: 25499314
    [Abstract] [Full Text] [Related]

  • 9. Fate of pre-differentiated mouse embryonic stem cells transplanted in unilaterally 6-hydroxydopamine lesioned rats: histological characterization of the grafted cells.
    Thinyane K, Baier PC, Schindehütte J, Mansouri A, Paulus W, Trenkwalder C, Flügge G, Fuchs E.
    Brain Res; 2005 May 31; 1045(1-2):80-7. PubMed ID: 15910765
    [Abstract] [Full Text] [Related]

  • 10. Effects of engrafted neural stem cells derived from GFP transgenic mice in Parkinson's diseases rats.
    Wei P, Liu J, Zhou HL, Han ZT, Wu QY, Pang JX, Liu S, Wang TH.
    Neurosci Lett; 2007 May 23; 419(1):49-54. PubMed ID: 17420097
    [Abstract] [Full Text] [Related]

  • 11. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M, Wang XJ, Zhang YH, Lu GQ, Liang L, Xu JY, Chen SD.
    Brain Res; 2007 Apr 20; 1142():206-16. PubMed ID: 17336273
    [Abstract] [Full Text] [Related]

  • 12. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H.
    Zhongguo Zhong Yao Za Zhi; 2014 May 20; 39(9):1660-5. PubMed ID: 25095380
    [Abstract] [Full Text] [Related]

  • 13. Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
    Inden M, Kim DH, Qi M, Kitamura Y, Yanagisawa D, Nishimura K, Tsuchiya D, Takata K, Hayashi K, Taniguchi T, Yoshimoto K, Shimohama S, Sumi S, Inoue K.
    Neurosci Lett; 2005 Oct 28; 387(3):151-6. PubMed ID: 16023291
    [Abstract] [Full Text] [Related]

  • 14. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.
    Liu WG, Lu GQ, Li B, Chen SD.
    Parkinsonism Relat Disord; 2007 Mar 28; 13(2):77-88. PubMed ID: 16963309
    [Abstract] [Full Text] [Related]

  • 15. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
    Mine Y, Hayashi T, Yamada M, Okano H, Kawase T.
    Neurosurgery; 2009 Oct 28; 65(4):741-53; discussion 753. PubMed ID: 19834380
    [Abstract] [Full Text] [Related]

  • 16. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
    Bagga V, Dunnett SB, Fricker RA.
    Behav Brain Res; 2015 Jul 15; 288():107-17. PubMed ID: 25841616
    [Abstract] [Full Text] [Related]

  • 17. Neural stem cells transplanted in a mouse model of Parkinson's disease differentiate to neuronal phenotypes and reduce rotational deficit.
    Ziavra D, Makri G, Giompres P, Taraviras S, Thomaidou D, Matsas R, Mitsacos A, Kouvelas ED.
    CNS Neurol Disord Drug Targets; 2012 Nov 01; 11(7):829-35. PubMed ID: 23131156
    [Abstract] [Full Text] [Related]

  • 18. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL, Chen SJ, Kao CL, Hung SC, Ding DC, Yu CC, Chen YJ, Ku HH, Lin CP, Lee KH, Chen YC, Wang JJ, Hsu CC, Chen LK, Li HY, Chiou SH.
    Cell Transplant; 2012 Nov 01; 21(1):313-32. PubMed ID: 21669041
    [Abstract] [Full Text] [Related]

  • 19. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR.
    Brain Res; 2009 Jun 18; 1276():39-49. PubMed ID: 19389387
    [Abstract] [Full Text] [Related]

  • 20. X-linked severe combined immunodeficiency (X-SCID) rats for xeno-transplantation and behavioral evaluation.
    Samata B, Kikuchi T, Miyawaki Y, Morizane A, Mashimo T, Nakagawa M, Okita K, Takahashi J.
    J Neurosci Methods; 2015 Mar 30; 243():68-77. PubMed ID: 25662444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.